1. Home
  2. COEP vs ZCMD Comparison

COEP vs ZCMD Comparison

Compare COEP & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • ZCMD
  • Stock Information
  • Founded
  • COEP 2017
  • ZCMD 2012
  • Country
  • COEP United States
  • ZCMD China
  • Employees
  • COEP N/A
  • ZCMD N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • ZCMD Other Consumer Services
  • Sector
  • COEP Health Care
  • ZCMD Real Estate
  • Exchange
  • COEP Nasdaq
  • ZCMD Nasdaq
  • Market Cap
  • COEP 32.4M
  • ZCMD 35.3M
  • IPO Year
  • COEP N/A
  • ZCMD 2020
  • Fundamental
  • Price
  • COEP $11.54
  • ZCMD $1.45
  • Analyst Decision
  • COEP
  • ZCMD
  • Analyst Count
  • COEP 0
  • ZCMD 0
  • Target Price
  • COEP N/A
  • ZCMD N/A
  • AVG Volume (30 Days)
  • COEP 136.7K
  • ZCMD 6.1K
  • Earning Date
  • COEP 03-25-2025
  • ZCMD 01-01-0001
  • Dividend Yield
  • COEP N/A
  • ZCMD N/A
  • EPS Growth
  • COEP N/A
  • ZCMD N/A
  • EPS
  • COEP N/A
  • ZCMD N/A
  • Revenue
  • COEP N/A
  • ZCMD $17,406,104.00
  • Revenue This Year
  • COEP N/A
  • ZCMD N/A
  • Revenue Next Year
  • COEP N/A
  • ZCMD N/A
  • P/E Ratio
  • COEP N/A
  • ZCMD N/A
  • Revenue Growth
  • COEP N/A
  • ZCMD 1.01
  • 52 Week Low
  • COEP $2.31
  • ZCMD $1.00
  • 52 Week High
  • COEP $13.70
  • ZCMD $5.10
  • Technical
  • Relative Strength Index (RSI)
  • COEP 59.40
  • ZCMD 44.73
  • Support Level
  • COEP $8.65
  • ZCMD $1.34
  • Resistance Level
  • COEP $13.70
  • ZCMD $1.51
  • Average True Range (ATR)
  • COEP 2.11
  • ZCMD 0.11
  • MACD
  • COEP -0.24
  • ZCMD 0.01
  • Stochastic Oscillator
  • COEP 61.22
  • ZCMD 39.66

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.

Share on Social Networks: